# Epinephrine Bitartrate, Lidocaine Hydrochloride Injection: FDA shortage status > FDA source status only. Nationwide status is not local pharmacy inventory. This page does not provide medical, treatment, substitution, or dosing advice. - Derived status: current - Source statuses: Current - FDA package records: 22 - Latest FDA row update: 08/07/2026 - Retrieved: 2026-08-22T15:54:11+00:00 ## FDA package and manufacturer records - Fresenius Kabi USA, LLC — Xylocaine, Injection, .005 mg/1 mL; 10 mg/1 mL (NDC 63323-487-17) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Xylocaine, Injection, .005 mg/1 mL; 10 mg/1 mL (NDC 63323-487-37) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Xylocaine, Injection, .005 mg/1 mL; 15 mg/1 mL (NDC 63323-488-17) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Xylocaine, Injection, .005 mg/1 mL; 15 mg/1 mL (NDC 63323-488-37) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Xylocaine, Injection, .005 mg/1 mL; 20 mg/1 mL (NDC 63323-489-17) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Xylocaine, Injection, .005 mg/1 mL; 20 mg/1 mL (NDC 63323-489-27) — FDA availability: Unavailable — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Xylocaine, Injection, .005 mg/1 mL; 5 mg/1 mL (NDC 63323-481-57) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Xylocaine, Injection, .01 mg/1 mL; 10 mg/1 mL (NDC 63323-482-17) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Xylocaine, Injection, .01 mg/1 mL; 10 mg/1 mL (NDC 63323-482-27) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Xylocaine, Injection, .01 mg/1 mL; 10 mg/1 mL (NDC 63323-482-57) — FDA availability: Unavailable — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Xylocaine, Injection, .01 mg/1 mL; 20 mg/1 mL (NDC 63323-483-27) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Xylocaine, Injection, .01 mg/1 mL; 20 mg/1 mL (NDC 63323-483-57) — FDA availability: Available — updated: 08/04/2026 - Hospira, Inc., a Pfizer Company — Lidocaine Hydrochloride And Epinephrine, Injection, 1 g/50 mL (2%; 1:100,000) (NDC 0409-3182-03) — FDA availability: Limited Availability — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Lidocaine Hydrochloride And Epinephrine, Injection, 2.5 g/50 mL (0.5%; 1:200,000) (NDC 0409-3177-01) — FDA availability: Unavailable — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Lidocaine Hydrochloride And Epinephrine, Injection, 200 mg/20 mL (1%; 1:100,000) (NDC 0409-3178-01) — FDA availability: Limited Availability — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Lidocaine Hydrochloride And Epinephrine, Injection, 300 mg/30 mL (1%; 1:100,000) (NDC 0409-3178-02) — FDA availability: Unavailable — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Lidocaine Hydrochloride And Epinephrine, Injection, 400 mg/20 mL (2%; 1:100,000) (NDC 0409-3182-01) — FDA availability: Unavailable — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Lidocaine Hydrochloride And Epinephrine, Injection, 400 mg/20 mL (2%; 1:200,000) (NDC 0409-3183-01) — FDA availability: Limited Availability — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Lidocaine Hydrochloride And Epinephrine, Injection, 450 mg/30 mL (1.5%; 1:200,000) (NDC 0409-3181-01) — FDA availability: Available — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Lidocaine Hydrochloride And Epinephrine, Injection, 500 mg/50 mL (1%; 1:100,000) (NDC 0409-3178-03) — FDA availability: Available — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Lidocaine Hydrochloride And Epinephrine, Injection, 75 mg/5 mL (1.5%; 1:200,000) (NDC 0409-1209-01) — FDA availability: Unavailable — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Lidocaine Hydrochloride and Epinephrine, Injection, 600 mg/30 mL (2%; 1:100,000) (NDC 0409-3182-02) — FDA availability: Limited Availability — updated: 08/07/2026 ## Sources and formats - [FDA openFDA source](https://api.fda.gov/drug/shortages.json) - [Canonical HTML](https://citefacts.com/shortages/epinephrine-bitartrate-lidocaine-hydrochloride-injection) - [JSON record](https://citefacts.com/shortages/epinephrine-bitartrate-lidocaine-hydrochloride-injection.json)